|
Ackman's $18 billion Pershing Square Capital
Management extended gains when its publicly traded fund rose 5.5
percent through Nov. 25, leaving it up 42 percent for the year
since January, a person familiar with the fund said. Final
numbers are still being calculated.
A big bet on Allergan helped boost returns at Pershing Square
when the Botox-maker's stock gained after the company agreed to
be sold to rival pharmaceutical company Actavis.
Einhorn's roughly $10 billion Greenlight Capital surged 5.8
percent last month and is now up 11 percent for the year as big
holdings like Apple and Marvell Technology Group rose, according
to an investor who was not permitted to speak on the record
about the fund because it is private.
Barry Rosenstein's Jana Partners Fund gained 3.1 percent in
November and is up 3.4 percent for the year, an investor said.
All beat the November increase in the Standard & Poor's 500
index.
Most hedge funds do not disclose their returns publicly since
the funds are private. Because of this, returns from some
big-name investors are closely watched for clues about the
industry's performance.
(Reporting by Svea Herbst-Bayliss; Editing by Alan Crosby)
[© 2014 Thomson Reuters. All rights
reserved.] Copyright 2014 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
 |
|
